XIAP-ULK1-mediated mitophagy modulates carnitine metabolism to mitigate diabetic kidney disease

Oct 26, 2025Autophagy

A cell cleaning process controlled by XIAP and ULK1 changes carnitine use to help reduce diabetic kidney disease

AI simplified

Abstract

XIAP upregulation is associated with impaired mitophagy and disrupted carnitine metabolism in diabetic kidney disease.

  • Mitophagy is essential for kidney health and is linked to mitochondrial function.
  • XIAP mediates the degradation of ULK1 through a specific tagging process, leading to impaired mitophagy.
  • Disruption of carnitine metabolism is observed alongside the impairment of mitophagy in diabetic models.
  • Restoring ULK1 expression using the agonist echinacoside and L-carnitine supplementation improves kidney function and mitochondrial health.
  • Targeting the XIAP-ULK1 pathway may be a promising therapeutic strategy for managing diabetic kidney disease.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free